CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
REVENUE
Revenue	$ 1,591,566		$ 1,591,566	$ 244,898
TOTAL REVENUE	1,591,566		1,591,566	244,898
OPERATING EXPENSES
Research and development	5,504,356	$ 2,513,915	15,585,143	9,307,512
General and administrative	2,564,960	1,800,630	7,637,461	5,496,186
TOTAL OPERATING EXPENSES	8,069,316	4,314,545	23,222,604	14,803,698
LOSS FROM OPERATIONS	(6,477,750)	(4,314,545)	(21,631,038)	(14,558,800)
OTHER INCOME (EXPENSE)
Other income		367,168	190,582	367,168
Investment income	106,635	15,570	141,836	41,476
Gain from forgiveness of debt				318,160
TOTAL OTHER INCOME (EXPENSE)	106,635	382,738	332,418	726,804
NET LOSS	(6,371,115)	(3,931,807)	(21,298,620)	(13,831,996)
OTHER COMPREHENSIVE INCOME (LOSS)
Net unrealized gain on marketable securities	99,637		122,467
COMPREHENSIVE INCOME (LOSS)	$ (6,271,478)	$ (3,931,807)	$ (21,176,153)	$ (13,831,996)
Net loss per share, basic	$ (0.26)	$ (0.17)	$ (0.87)	$ (0.61)
Net loss per share, diluted	$ (0.26)	$ (0.17)	$ (0.87)	$ (0.61)
Weighted-average number of shares of common stock outstanding basic	24,431,787	23,095,375	24,346,775	22,731,638
Weighted-average number of shares of common stock outstanding diluted	24,431,787	23,095,375	24,346,775	22,731,638